Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Innovation, Technology Integration, and New Customer Segments to Drive New Business Growth
save 15 %
* Required Fields
Pay by invoice
There is high growth in the Asia-Pacific (APAC) oncology diagnostics market due to increasing incidence of cancer and the drastic reduction in incidence age owing to a plethora of reasons in the regional market. The major drivers for the APAC cancer diagnostics market are increase in adoption of technology platforms, access to targeted cancer therapeutics and increased demand from patients for affordable and quality care. Furthermore, the global push toward precision medicine has gradually propelled the uptake of innovative platforms such as Next-generation Sequencing (NGS) and liquid biopsy for gradual adoption into mainstream clinical diagnosis. The study examines the APAC oncology diagnostics market, focused on 6 high-prevalence cancers, namely, breast, lung, prostate, colorectal, cervical, and ovarian cancer. The scope of the study includes 10 countries: Japan, China, India, South Korea, Australia, Singapore, Malaysia, Indonesia, Thailand, and Vietnam, with country-level market share and top trends and opportunities driving the oncology diagnostics market. Furthermore, the study identifies the top growth opportunities and market trends that are set to transform the future landscape of oncology diagnostics in APAC. NGS solutions are gradually moving from research to clinical applications, with major regional companies investing in molecular diagnostics as a future growth segment. Luye Pharma’s acquisition of Vela Diagnostics, the Genome Asia 100K initiative by Macrogen, multiplexed diagnostic solutions from Seegene Diagnostics, and liquid biopsy tools from Sysmex Inostics are a few examples of trending topics in APAC that will impact the oncology diagnostics market. The market, whose revenue stood at $873.7 million in 2016, is expected to generate a revenue of $1,149.1 million by 2021, growing at a Compound Annual Growth Rate (CAGR) of 5.6%.In addition to the above-mentioned data points, the study also provides information in terms of the key participants across the market by different cancer types as well as some of the new entrants in the market. The following are some key questions that this study will answer.• What is the current market scenario for oncology diagnostics in Asia? • What are the emerging cancers in Asia with high-growth opportunities in In-vitro Diagnostics (IVD)? • What are the regional dynamics currently trending in Asia to combat the rising prominence of cancer, precisely through early screening and surveillance programs? • What is the penetration of novel diagnostic solutions across the oncology care continuum?• What are the challenges and barriers to address in accelerating the uptake of novel screening or cancer diagnostic tests in Asia? • What are the growth opportunities for IVD companies to tap into in the APAC oncology diagnostics market?
US Cardiac Troponin Diagnostics Market, Forecast to 2021
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Oncology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017
Strategic Insight into the Global Women’s Reproductive Health Diagnostics Market, 2017
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
nutritional supplement market
agricultural drones market
food waste market
alternative energy market
solar energy market
power electronics market
diabetes care devices market
digital signage market
cloud security market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.